Costacurta Antonia, Priante Giovanna, D'Angelo Angela, Chieco-Bianchi Luigi, Cantaro Salvatore
Department of Medical and Surgical Sciences, Nephrology, University of Padova, Padova, Italy.
J Clin Lab Anal. 2002;16(4):178-86. doi: 10.1002/jcla.10038.
The proteoglycan decorin inhibits TGF-beta; therefore, it could antagonize progression of fibrotic diseases associated with activation of TGF-beta(1). The effect of decorin transfection in human mesangial cells (HMCs) on the expression of genes related to kidney fibrosis was investigated. HMCs, isolated from glomeruli of healthy portions of human kidneys removed due to carcinoma, were histochemically typed. Decorin cDNA cloned in a eukaryotic expression vector was transfected into HMCs. Gene expression of fibrogenetic cytokines and fibrotic proteins TGF-beta(1), PDGF-beta, alpha(1) collagen type IV, alpha(1) collagen type I, fibronectin, and tenascin was analyzed, by reverse transcription polymerase chain reaction (RT-PCR), 24 hr after transfection. Immunoblotting analysis of protein extracts using anti-decorin IgG, revealed a positive signal of about 52 MDa, corresponding to the molecular weight of decorin, in cultures transfected with the decorin gene. Decorin mRNA increased about 12 times in cultures transfected with the construct pCR3.1-Deco. Cells with increased decorin synthesis showed a 61% decrease of TGF-beta(1) mRNA, a 71% reduction of alpha1 collagen type IV mRNA, and a 29% reduction of fibronectin mRNA. This study is the first to investigate decorin transfection into human mesangial cells, and supports the use of the decorin gene to control the progression of glomerular and interstitial fibrosis in kidney diseases.
核心蛋白聚糖可抑制转化生长因子-β(TGF-β);因此,它可能拮抗与TGF-β(1)激活相关的纤维化疾病的进展。研究了核心蛋白聚糖转染人系膜细胞(HMCs)对肾纤维化相关基因表达的影响。从因癌症而切除的人肾健康部分的肾小球中分离出HMCs,并进行组织化学分型。将克隆于真核表达载体中的核心蛋白聚糖cDNA转染到HMCs中。转染24小时后,通过逆转录聚合酶链反应(RT-PCR)分析促纤维化细胞因子和纤维化蛋白TGF-β(1)、血小板衍生生长因子-β(PDGF-β)、IV型α1胶原蛋白、I型α1胶原蛋白、纤连蛋白和腱生蛋白的基因表达。使用抗核心蛋白聚糖IgG对蛋白提取物进行免疫印迹分析,发现在转染核心蛋白聚糖基因的培养物中出现了一条约52 kDa的阳性条带,与核心蛋白聚糖的分子量相对应。在用构建体pCR3.1-Deco转染的培养物中,核心蛋白聚糖mRNA增加了约12倍。核心蛋白聚糖合成增加的细胞中,TGF-β(1)mRNA减少了61%,IV型α1胶原蛋白mRNA减少了71%,纤连蛋白mRNA减少了29%。本研究首次探讨了核心蛋白聚糖转染人系膜细胞的情况,并支持使用核心蛋白聚糖基因来控制肾脏疾病中肾小球和间质纤维化的进展。